InvestorsHub Logo
Followers 1
Posts 972
Boards Moderated 0
Alias Born 02/14/2018

Re: None

Tuesday, 09/11/2018 3:06:48 PM

Tuesday, September 11, 2018 3:06:48 PM

Post# of 108192
https://www.msn.com/en-us/finance/topstocks/mercks-keytruda-combo-gets-nod-for-lung-cancer-in-europe/ar-BBNbcb3

Keytruda approved in Europe for first-line combination treatment for NSCLC.

Now let's get that NSCLC HOT indication into clinical!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News